Resmetirom plus maximally tolerated therapy lowers LDL in heterozygous FH vs. placebo
Great to have more therapies for FH
Related Articles
Temple Health and Fox Chase Cancer Center Researchers Find That Breast Cancer Surgical Reimbursements Declined Significantly Over Last 20 Years
PHILADELPHIA (April 15, 2024) — With potential implications for quality-of-care and access to services, Medicare reimbursement for most common breast cancer surgeries declined significantly over…
Plan for world’s tallest wind turbine with 1,200ft tower set to dwarf Shard
GERMANY is set to build the world’s tallest wind turbine that will surpass the height of the Shard. Incredible plans have been revealed for the…
Refining the impact of genetic evidence on clinical success
Nature – Human genetic evidence increases the success rate of drugs from clinical development to approval but we are still far from reaching peak genetic…
The fake diagnoses of so-called alternative medicine – PART 1
We all have heard of so-called alternative therapies but few of us are aware of the fact that there are also alternative diagnoses. These are…
What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies
Use of surrogates as primary endpoints is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are endpoints th
Resisting a Drop in Standards
Kirk L. Smick argues that preservative-free eye drops should be the standard of care for glaucoma patients
Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis
To estimate the proportion of healthcare interventions tested within Cochrane Reviews that are effective according to high-quality evidence.We selecte…
Increased Cortical Thickness Seen in Brain Areas Linked to… : Neurology Today
An abstract is unavailable.
What Is Slugging and Should You Try It?
The viral skin care routine known as slugging, or slathering your face with petroleum jelly overnight, could actually revolutionize your skin. A dermatologist explains.
SGLT2 Inhibitors and Major Adverse CV Outcomes – American College of Cardiology
Debabrata Mukherjee, MD, FACC
